The rare congenital bleeding disorders are a heterogeneous group of diseases which include deficiencies of fibrinogen, prothrombin and factors V, V + VIII, VII, X, XI and XIII. They are usually transmitted as autosomal recessive disorders, and the prevalence of the severe forms ranges from one case in 500,000 for factor VII up to one in 2,000,000 for factor XIII in the general population. Patients with rare congenital bleeding disorders may have a broad spectrum of clinical symptoms, ranging from mucocutaneous bleeding to life-threatening haemorrhages, such as those occurring in the central nervous system. The treatment of these disorders is based principally on the replacement of the deficient factor using, when available, specific plasma-derived or recombinant products. The aim of this narrative review is to summarise current knowledge about these rare bleeding conditions.

Rare congenital bleeding disorders / Franchini, Massimo; Marano, Giuseppe; Pupella, Simonetta; Vaglio, Stefania; Masiello, Francesca; Veropalumbo, Eva; Piccinini, Vanessa; Pati, Ilaria; Catalano, Liviana; Liumbruno, Giancarlo Maria. - In: ANNALS OF TRANSLATIONAL MEDICINE. - ISSN 2305-5839. - 6:17(2018), pp. 1-8. [10.21037/atm.2018.08.34]

Rare congenital bleeding disorders

Vaglio, Stefania;
2018

Abstract

The rare congenital bleeding disorders are a heterogeneous group of diseases which include deficiencies of fibrinogen, prothrombin and factors V, V + VIII, VII, X, XI and XIII. They are usually transmitted as autosomal recessive disorders, and the prevalence of the severe forms ranges from one case in 500,000 for factor VII up to one in 2,000,000 for factor XIII in the general population. Patients with rare congenital bleeding disorders may have a broad spectrum of clinical symptoms, ranging from mucocutaneous bleeding to life-threatening haemorrhages, such as those occurring in the central nervous system. The treatment of these disorders is based principally on the replacement of the deficient factor using, when available, specific plasma-derived or recombinant products. The aim of this narrative review is to summarise current knowledge about these rare bleeding conditions.
2018
rare bleeding disorders; congenital; prophylaxis; treatment
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Rare congenital bleeding disorders / Franchini, Massimo; Marano, Giuseppe; Pupella, Simonetta; Vaglio, Stefania; Masiello, Francesca; Veropalumbo, Eva; Piccinini, Vanessa; Pati, Ilaria; Catalano, Liviana; Liumbruno, Giancarlo Maria. - In: ANNALS OF TRANSLATIONAL MEDICINE. - ISSN 2305-5839. - 6:17(2018), pp. 1-8. [10.21037/atm.2018.08.34]
File allegati a questo prodotto
File Dimensione Formato  
Franchini_Rare-congenital_2018.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 209.72 kB
Formato Adobe PDF
209.72 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1180652
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 11
social impact